Matrix Metalloproteinases as Therapeutic Targets for Idiopathic Pulmonary Fibrosis

Cited by (507)

Items 101–200 of 507

1. Understanding fibrosis: Mechanisms, clinical implications, current therapies, and prospects for future interventions
   Jennifer C. Ku, Jacob Raiten, Yong Li · 2024 · Biomedical Engineering Advances
2. Inhibitory effects of total ginsenoside on bleomycin-induced pulmonary fibrosis in mice
   Lu Yang, Pan‐pan Chen, Min Luo, Wanlan Shi, Dong-shun Hou, Yang Gao, Shangfu Xu, Jiang Deng · 2019 · Biomedicine & Pharmacotherapy
3. Sodium Propionate Attenuates the Lipopolysaccharide-Induced Epithelial–Mesenchymal Transition via the PI3K/Akt/mTOR Signaling Pathway
   Dan Chen, Yu-bao Qiu, Zhi-qi Gao, Yaxian Wu, Bin-bin Wan, Gang Liu, Junliang Chen, Qin Zhou, Renqiang Yu, Qingfeng Pang · 2020 · Journal of Agricultural and Food Chemistry
4. The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs
   Hao Shen, Nu Zhang, Yuqing Liu, Xuerong Yang, Yuanyuan He, Qi Li, Xiaoyan Shen, Yulian Zhu, Yong Mo Yang · 2022 · Frontiers in Pharmacology
5. Appropriate level of cuproptosis may be involved in alleviating pulmonary fibrosis
   Guoxing Li, Lihua Peng, Mingjun Wu, Yipin Zhao, Zhe Cheng, Gang Li · 2022 · Frontiers in Immunology
6. Increased Ratio of Matrix Metalloproteinase-9 (MMP-9)/Tissue Inhibitor Metalloproteinase-1 from Alveolar Macrophages in Chronic Asthma with a Fast Decline in FEV1 at 5-Year Follow-up
   Fu‐Tsai Chung, Hung-Yu Huang, Chun‐Yu Lo, Yu‐Chen Huang, Changwei Lin, Chih-Chen He, Jung‐Ru He, Te‐Fang Sheng, Chun‐Hua Wang · 2019 · Journal of Clinical Medicine
7. The Versatile Role of Matrix Metalloproteinase for the Diverse Results of Fibrosis Treatment
   Hong-Meng Chuang, Yu-Shuan Chen, Horng‐Jyh Harn · 2019 · Molecules
8. Irreversible Bladder Remodeling Induced by Fibrosis
   Su Jin Kim, Jayoung Kim, Yong Gil Na, Khae Hawn Kim · 2021 · International Neurourology Journal
9. Copper as the most likely pathogenic divergence factor between lung fibrosis and emphysema
   Rob Janssen, Bart de Brouwer, Jan H. von der Thüsen, Emiel F.�M. Wouters · 2018 · Medical Hypotheses
10. Alveolar heparan sulfate shedding impedes recovery from bleomycin-induced lung injury
    Wells B. LaRivière, S. Liao, Sarah A. McMurtry, Kaori Oshima, Xiaorui Han, F. Zhang, Shaomin Yan, Sarah M. Haeger, Monica Ransom, Julie A. Bastarache et al. · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
11. TIMP-1 and its potential diagnostic and prognostic value in pulmonary diseases
    Sultan Almuntashiri, Abdullah Alhumaid, Yin Zhu, Yohan Han, Saugata Dutta, Ohmed Khilji, Duo Zhang, Xiaoyun Wang · 2023 · Chinese Medical Journal - Pulmonary and Critical Care Medicine
12. Mechanical forces amplify TCR mechanotransduction in T cell activation and function
    Nicholas C. Jeffreys, Joshua M. Brockman, Yunhao Zhai, Donald E. Ingber, David J. Mooney · 2024 · Applied Physics Reviews
13. ALKBH5 SUMOylation-mediated FBXW7 m6A modification regulates alveolar cells senescence during 1-nitropyrene-induced pulmonary fibrosis
    Se-Ruo Li, Ningning Kang, Rong-Rong Wang, Meng‐Die Li, Lihong Chen, Peng Zhou, De‐Xiang Xu, Hui Zhao, Lin Fu · 2024 · Journal of Hazardous Materials
14. Probing ECM remodeling in idiopathic pulmonary fibrosis via second harmonic generation microscopy analysis of macro/supramolecular collagen structure
    Darian S. James, Alexander N. Jambor, Hsin-Yu Chang, Zachary Alden, Karissa Beth Tilbury, Nathan K. Sandbo, Paul J. Campagnola · 2019 · Journal of Biomedical Optics
15. Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case–control study
    Changjiang Xue, Na Wu, Xue Li, Meihua Qiu, Xuqin Du, Qiao Ye · 2017 · BMC Pulmonary Medicine
16. Human Endometrial Regenerative Cells Attenuate Bleomycin-Induced Pulmonary Fibrosis in Mice
    Yiming Zhao, Lan Xu, Yong Wang, Xiaoxi Xu, Shanzheng Lu, Xiang Li, Baoren Zhang, Ganggang Shi, Xiangying Gu, Caigan Du et al. · 2018 · Stem Cells International
17. NETosis promotes chronic inflammation and fibrosis in systemic lupus erythematosus and COVID-19
    Huiqing Lin, Jiejie Liu, Ning Li, Birong Zhang, Van Dien Nguyen, Peipei Yao, Jiangpeng Feng, Qianyun Liu, Yu Zheng Chen, Guang Li et al. · 2023 · Clinical Immunology
18. Modeling pulmonary fibrosis through bleomycin delivered by osmotic minipump: a new histomorphometric method of evaluation
    Francesca Ravanetti, Luisa Ragionieri, Roberta Ciccimarra, Francesca Ruscitti, Daniela Pompilio, Ferdinando Gazza, Gino Villetti, Antonio Cacchioli, Franco Fabio Stellari · 2019 · American Journal of Physiology-Lung Cellular and Molecular Physiology
19. Matrix metallopeptidase expression and modulation by transforming growth factor-β1 in equine endometrosis
    Anna Zuzanna Szóstek-Mioduchowska, Mariola Słowińska, Joanna Pacewicz, Dariusz Jan Skarzynski, Kiyoshi Okuda · 2020 · Scientific Reports
20. Alveolar epithelial cells and microenvironmental stiffness synergistically drive fibroblast activation in three-dimensional hydrogel lung models
    Thomas Caracena, Rachel Blomberg, Rukshika S. Hewawasam, Zoe E. Fry, David W. H. Riches, Chelsea M. Magin · 2022 · Biomaterials Science
21. Cardioprotection of salvianolic acid B and ginsenoside Rg1 combination on subacute myocardial infarction and the underlying mechanism
    Yuanmin Li, Linlin Wang, Zhihui Dong, Shiying Wang, Lili Qi, Kenka Cho, Zhou Zhang, Na Li, Yurong Hu, Baohong Jiang · 2018 · Phytomedicine
22. MMP Activity Detection in Zymograms
    Péter Bencsik, Monika Barteková, Anikó Görbe, Krisztina Kiss, János Pálóczi, Jana Radošinská, Gergő Szűcs, Péter Ferdinándy · 2017 · Methods in molecular biology
23. Searching for novel PET radiotracers: imaging cardiac perfusion, metabolism and inflammation.
    Caitlund Davidson, Christopher P. Phenix, Tze Chun Tai, Neelam Khaper, Simon James Lees · 2018 · Europe PMC (PubMed Central)
24. Hermansky-Pudlak Syndrome and Lung Disease: Pathogenesis and Therapeutics
    Pamela Velázquez-Díaz, Erika Nakajima, Parand Sorkhdini, Ashley Hernandez-Gutierrez, Adam T. Eberle, Dongqin Yang, Yang Zhou · 2021 · Frontiers in Pharmacology
25. A construct of adipose-derived mesenchymal stem cells—laden collagen scaffold for fertility restoration by inhibiting fibrosis in a rat model of endometrial injury
    Yangyang Dai, Liaobing Xin, Sentao Hu, Shiqian Xu, Dong Huang, Xiaoying Jin, Jianmin Chen, Rachel Chan, Ernest Hung Yu Ng, William S.B. Yeung et al. · 2023 · Regenerative Biomaterials
26. Endometrial Regeneration in Asherman's Syndrome: Clinical and Translational evidence of Stem Cell Therapies
    Xuejing Hou, Ying Liu, Isabelle Streuli, Patrick Dällenbach, Jean Bernard Dubuisson, Yveline Ansaldi, Nicola Pluchino · 2019 · Current Stem Cell Research & Therapy
27. Engineering of tissue inhibitor of metalloproteinases TIMP-1 for fine discrimination between closely related stromelysins MMP-3 and MMP-10
    Maryam Raeeszadeh‐Sarmazdeh, Matt Coban, Shivansh Mahajan, Alexandra Hockla, Banumathi Sankaran, Gregory Paul Downey, Derek C. Radisky, Evette S. Radisky · 2022 · Journal of Biological Chemistry
28. Nickle(II) ions exacerbate bleomycin-induced pulmonary inflammation and fibrosis by activating the ROS/Akt signaling pathway
    Lawei Yang, Ziying Lin, Yahong Wang, Chunyan Li, Wenya Xu, Qinglan Li, Weimin Yao, Zeqing Song, Gang Liu · 2017 · Environmental Science and Pollution Research
29. PARP1 stabilizes FOXN3 to suppress pulmonary fibrosis through p38-related feedback regulation
    Xinxing Zhu, Qingyang Huo, Lele Jin, Jiang Du, Jinjin Yu, Huanhuan Wang, Nan Wu, Yingke Li, Yan Rui, chengling Zhao et al. · 2026 · Science Advances
30. Iguratimod ameliorates bleomycin‐induced alveolar inflammation and pulmonary fibrosis in mice by suppressing expression of matrix metalloproteinase‐9
    Like Zhao, Bingyao Mu, Rongwei Zhou, Yongjing Cheng, Cibo Huang · 2019 · International Journal of Rheumatic Diseases
31. Dissecting the novel mechanism of reduning injection in treating Coronavirus Disease 2019 (COVID-19) based on network pharmacology and experimental verification
    Shanshan Jia, Hua Luo, Xinkui Liu, Xiaotian Fan, Zhihong Huang, Shan Lu, Liangliang Shen, Siyu Guo, Yingying Liu, Zhenzhong Wang et al. · 2021 · Journal of Ethnopharmacology
32. Inflammation, ageing and diseases of the lung: Potential therapeutic strategies from shared biological pathways
    Aduragbemi A. Faniyi, Michael Hughes, Aaron Scott, Kylie B. R. Belchamber, Elizabeth Sapey · 2021 · British Journal of Pharmacology
33. Molecular and Genetic Biomarkers in Idiopathic Pulmonary Fibrosis: Where Are We Now?
    Ioannis P. Tomos, Ioannis Roussis, Andreas Μ. Matthaiou, Katerina Dimakou · 2023 · Biomedicines
34. Drug repurposing in idiopathic pulmonary fibrosis filtered by a bioinformatics-derived composite score
    Evangelos Karatzas, Marilena M. Bourdakou, George C. Kolios, George M. Spyrou · 2017 · Scientific Reports
35. Leveraging 3D Model Systems to Understand Viral Interactions with the Respiratory Mucosa
    Ethan Iverson, Logan Kaler, Eva L. Agostino, Daniel Song, Gregg A. Duncan, Margaret A. Scull · 2020 · Viruses
36. Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage Polarization
    Yingfeng Shi, Jinqing Li, Hui Chen, Yan Hu, Lunxian Tang, Xun Zhou, Min Tao, Zexin Lv, Si Chen, Andong Qiu et al. · 2022 · Frontiers in Immunology
37. Therapeutic strategies targeting pro-fibrotic macrophages in interstitial lung disease
    Takuma Isshiki, Megan Vierhout, Safaa Naiel, Pareesa Ali, Parichehr Yazdanshenas, Vaishnavi R. Kumaran, Zi Yang, Anna Dvorkin‐Gheva, Anthony F. Rullo, Martin R.J. Kolb et al. · 2023 · Biochemical Pharmacology
38. Advancing Treatment Strategies: A Comprehensive Review of Drug Delivery Innovations for Chronic Inflammatory Respiratory Diseases
    Junming Wang, Pengfei Wang, Yiru Shao, Daikun He · 2023 · Pharmaceutics
39. Triptolide attenuates pulmonary fibrosis by inhibiting fibrotic extracellular matrix remodeling mediated by MMPs/LOX/integrin
    Weiji Lin, Yaqin Song, Tingting Li, Jiahui Yan, Ruiyuan Zhang, Liang Han, Xin Ba, Yao Huang, Kai Qin, Zhe Chen et al. · 2023 · Biomedicine & Pharmacotherapy
40. The TIMP protein family: diverse roles in pathophysiology
    Sasha Coates-Park, Joshua A. Rich, William George Stetler‐Stevenson, David Peeney · 2024 · American Journal of Physiology-Cell Physiology
41. Copper homeostasis dysregulation in respiratory diseases: a review of current knowledge
    Wei Song, Yuanyi Yue, Qiang Zhang, Xueqing Wang · 2024 · Frontiers in Physiology
42. Morphological and molecular motifs of fibrosing pulmonary injury patterns
    Danny David Jonigk, Helge Stark, Peter Braubach, Lavinia Neubert, Hoen‐oh Shin, Nicole Izykowski, Tobias Welte, Sabina M Janciauskiene, G. Warnecke, Axel Haverich et al. · 2019 · The Journal of Pathology Clinical Research
43. Combined intervention with N-acetylcysteine and desipramine alleviated silicosis development by regulating the Nrf2/HO-1 and ASMase/ceramide signaling pathways
    Meng Tang, Zhihui Yang, Jing Liu, Xiangfei Zhang, Lan Guan, Xinming Liu, Ming Zeng · 2022 · Ecotoxicology and Environmental Safety
44. Cellular and Molecular Mechanism of Pulmonary Fibrosis Post-COVID-19: Focus on Galectin-1, -3, -8, -9
    Daniela Adriana Oatis, Erika Simon-Repolski, Cornel Baltă, Alin Gabriel Mihu, Gorizio Pieretti, Roberto Alfano, Luisa Peluso, Maria Consiglia Trotta, Michele D’Amico, Anca Oana Hermenean · 2022 · International Journal of Molecular Sciences
45. Idiopathic Pulmonary Fibrosis: Review of Current Knowledge
    Jozef Muri, Barbora Durcová, Róbert Slivka, Adela Vrbenská, Mária Makovická, P Makovický, Jozef Škarda, Patricie Delongová, Vojtěch Kamarád, Janka Vecanová · 2024 · Physiological Research
46. USP25 stabilizes STAT6 to promote IL-4-induced macrophage M2 polarization and fibrosis
    Yu Xu, Jing Liu, Jingzeng Wang, Jiayao Wang, Peixiang Lan, Tao Wang · 2024 · International Journal of Biological Sciences
47. Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity and Sequelae
    Gustavo Ramírez-Martínez, Luis Armando Jiménez-Álvarez, Alfredo Cruz‐Lagunas, Sergio Ignacio-Cortés, Itzel Alejandra Gómez-García, Tatiana Sofia Rodríguez-Reyna, José Alberto Choreño-Parra, Joaquín Zúñiga · 2022 · Journal of Interferon & Cytokine Research
48. Activation of MMPs in Macrophages by Mycobacterium tuberculosis via the miR‐223‐BMAL1 Signaling Pathway
    Jun Lou, Yongli Wang, Zhimin Zhang, Weiqiang Qiu · 2017 · Journal of Cellular Biochemistry
49. Perspectives of PDE inhibitor on treating idiopathic pulmonary fibrosis
    Xudan Yang, Zhihao Xu, Songhua Hu, Juan Shen · 2023 · Frontiers in Pharmacology
50. Roles of MMP-2 and MMP-9 and their associated molecules in the pathogenesis of keloids: a comprehensive review
    Yajie Wang, Liying Zheng, Lai Zhang, Yuncheng Tai, Xuesong Lin, Zhencheng Cai · 2024 · Frontiers in Pharmacology
51. Epithelial Cell Dysfunction in Pulmonary Fibrosis: Mechanisms, Interactions, and Emerging Therapeutic Targets
    Jing Wang, Jie Chao · 2025 · Pharmaceuticals
52. Predictive biomarkers of disease progression in idiopathic pulmonary fibrosis
    Weiwei Zhu, Chunquan Liu, Chunting Tan, Jie Zhang · 2023 · Heliyon
53. Preference of Aerosolized Pirfenidone to Oral Intake: An Experimental Model of Pulmonary Fibrosis by Paraquat
    Rokhsana Rasooli, Hamid Rajaian, Abbas Pardakhty, Ali Mandegary · 2017 · Journal of Aerosol Medicine and Pulmonary Drug Delivery
54. Progressive Lung Injury, Inflammation, and Fibrosis in Rats Following Inhalation of Sulfur Mustard
    Rama Malaviya, Елена Владимировна Абрамова, Raymond C. Rancourt, Vasanthi R. Sunil, Marta Napierała, Daniel Weinstock, Claire R. Croutch, Julie Roseman, Rick Tuttle, Eric Peters et al. · 2020 · Toxicological Sciences
55. Role of various imbalances centered on alveolar epithelial cell/fibroblast apoptosis imbalance in the pathogenesis of idiopathic pulmonary fibrosis
    Qing Wang, Zhaoliang Xie, Qi Wu, Zhixian Jin, Chao Yang, Jing Feng · 2021 · Chinese Medical Journal
56. Matrix metalloproteinases inhibitors in idiopathic pulmonary fibrosis: Medicinal chemistry perspectives
    Yue Lin, Yaojie Shi, Xingping Su, Liang Ouyang, Guan Wang, Tinghong Ye · 2021 · European Journal of Medicinal Chemistry
57. Mechanobiology and the extracellular matrix in pulmonary fibrosis
    Ingo Ganzleben, Benjamin D. Medoff · 2025 · iScience
58. An atypical pulmonary fibrosis is associated with co-inheritance of mutations in the calcium binding protein genesS100A3andS100A13
    Eid Al Mutairy, Faiqa Imtiaz, Mohammed Khalid, Somaya M. Al Qattan, Soad M. Saleh, Linah Mahmoud, Maher Al‐Saif, Latifa Al‐Haj, Azizah A. Al-Enazi, Abdullah Aljebreen et al. · 2019 · European Respiratory Journal
59. Effect and Mechanism of Qingfei Paidu Decoction in the Management of Pulmonary Fibrosis and COVID-19
    Yu Wu, Lili Xu, Gang Cao, Lingtian Min, Tingting Dong · 2021 · The American Journal of Chinese Medicine
60. Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis
    Suh‐Young Lee, Chang-Min Lee, Bing Ma, Suchitra Kamle, Jack A. Elias, Yang Zhou, Chun Geun Lee · 2022 · Frontiers in Pharmacology
61. Mycobacterium avium-intracellulare complex promote release of pro-inflammatory enzymes matrix metalloproteinases by inducing neutrophil extracellular trap formation
    Kota Nakamura, Hitoshi Nakayama, Shinichi Sasaki, Kazuhisa Takahashi, Kazuhisa Iwabuchi · 2022 · Scientific Reports
62. Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension
    Mattias Arvidsson, Abdulla Ahmed, Habib Bouzina, Göran Rådegran · 2019 · Pulmonary Circulation
63. Targeting the NF-κB p65-MMP28 axis: Wogonoside as a novel therapeutic agent for attenuating podocyte injury in diabetic nephropathy
    Xiandeng Li, Shuyan Zhao, Jing Xie, Li Mi, Shuangmei Tong, Jing Ma, Rui Yang, Qinjian Zhao, Jian Zhang, Ajing Xu · 2025 · Phytomedicine
64. Pirfenidone regulates LPS mediated activation of neutrophils
    Shankar Jaikishan Evani, S. L. Rajasekhar Karna, Janakiram Seshu, Kai P. Leung · 2020 · Scientific Reports
65. MMP-3-mediated cleavage of OPN is involved in copper oxide nanoparticle-induced activation of fibroblasts
    Zhang, Yuanbao, Mo, Yiqun, Zhang, Yue, Yuan, Jiali, Zhang, Qunwei · 2023 · Particle and Fibre Toxicology
66. Identification of Circulating Fibrocytes and Dendritic Derivatives in Corneal Endothelium of Patients With Fuchs' Dystrophy
    An‐Katrien De Roo, Jasper Wouters, Olivier Govaere, Beatrijs J. J. Foets, Joost J. van den Oord · 2017 · Investigative Ophthalmology & Visual Science
67. Chemokine signaling axis between endothelial and myeloid cells regulates development of pulmonary hypertension associated with pulmonary fibrosis and hypoxia
    Aline Cristina da Silva Oliveira, Chunhua Fu, Yuanqing Lu, Mason A. Williams, Liya Pi, Mark Brantly, Corey E. Ventetuolo, Mohan K. Raizada, Borna Mehrad, Edward W. Scott et al. · 2019 · American Journal of Physiology-Lung Cellular and Molecular Physiology
68. Matrix metalloproteinase activity in the lung is increased in Hermansky-Pudlak syndrome
    Ross S. Summer, Rachana Krishna, DeLeila Schriner, Karina Cuevas-Mora, Dominic Sales, Rachel Para, Jesse Roman, Carl Nieweld, Bernadette R. Gochuico, Freddy Romero · 2019 · Orphanet Journal of Rare Diseases
69. Extracellular vesicles as advanced therapeutics for the resolution of organ fibrosis: Current progress and future perspectives
    Ke Lv, Yizhuo Wang, Peng Lou, Shuyun Liu, Pingya Zhou, Li Yang, Yanrong Lu, Jingqiu Cheng, Jingping Liu · 2022 · Frontiers in Immunology
70. An overview of matrix metalloproteinase-12 in multiple disease conditions, potential selective inhibitors, and drug designing strategies
    Jigme Sangay Dorjay Tamang, Suvankar Banerjee, Sandip Kumar Baidya, Sanjib Das, Balaram Ghosh, Tarun Jha, Nilanjan Adhikari · 2024 · European Journal of Medicinal Chemistry
71. ADAM15 expression is increased in lung CD8+ T cells, macrophages, and bronchial epithelial cells in patients with COPD and is inversely related to airflow obstruction
    Xiaoyun Wang, Duo Zhang, Andrew Higham, Sophie Wolosianka, Xiaoyan Gai, Lu Zhou, Hans V. Petersen, Víctor Pinto-Plata, Miguel J. Divo, Edwin K. Silverman et al. · 2020 · Respiratory Research
72. Efficient pulmonary fibrosis therapy via regulating macrophage polarization using respirable cryptotanshinone-loaded liposomal microparticles
    Xiuhua Wang, Wei Wan, Jiguo Zhang, Jing Lü, Peiqing Liu · 2023 · Journal of Controlled Release
73. Pathological and therapeutic aspects of matrix metalloproteinases: Implications in osteosarcoma
    Huayan Tang, Zhaohui Tang, Yong‐Jun Jiang, Weisheng Wei, Jian Lü · 2019 · Asia-Pacific Journal of Clinical Oncology
74. Protective Role of Matrix Metalloproteinase-2 in Allergic Bronchial Asthma
    Yoshinori Takahashi, Tetsu Kobayashi, Corina N. D’Alessandro‐Gabazza, Masaaki Toda, Kentaro Fujiwara, Tomohito Okano, Hajime Fujimoto, Kentaro Asayama, Atsuro Takeshita, Taro Yasuma et al. · 2019 · Frontiers in Immunology
75. Advances in idiopathic pulmonary fibrosis diagnosis and treatment
    Hongli Liu, Jiaxi Shen, Chao He · 2025 · Chinese Medical Journal - Pulmonary and Critical Care Medicine
76. Amelioration of Pulmonary Fibrosis by Matrix Metalloproteinase-2 Overexpression
    Ryo Inoue, Taro Yasuma, Valeria Fridman D’Alessandro, Masaaki Toda, Toshiyuki Ito, Atsushi Tomaru, Corina N. D’Alessandro‐Gabazza, Tatsuki Tsuruga, Tomohito Okano, Atsuro Takeshita et al. · 2023 · International Journal of Molecular Sciences
77. Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers
    Fotios Drakopanagiotakis, Philipp Markart, Paschalis Steiropoulos · 2023 · International Journal of Molecular Sciences
78. Matrix Metalloproteinases
    William C. Parks · 2021 · Elsevier eBooks
79. Neutrophils in Bronchoalveolar Lavage Fluid Indicating the Severity and Relapse of Pulmonary Sarcoidosis
    Haoshen Feng, Lili Yan, Yabin Zhao, Zhenhua Li, Jian Kang · 2022 · Frontiers in Medicine
80. Kefir peptides mitigate bleomycin-induced pulmonary fibrosis in mice through modulating oxidative stress, inflammation and gut microbiota
    Ying‐Wei Lan, Ying-Cheng Chen, Chih‐Ching Yen, Hsiao‐Ling Chen, Min‐Che Tung, Hueng‐Chuen Fan, Chuan‐Mu Chen · 2024 · Biomedicine & Pharmacotherapy
81. Matrix metalloproteinases and their tissue inhibitors as upcoming biomarker signatures of connective tissue diseases-related interstitial lung disease: towards an earlier and accurate diagnosis
    Verónica Pulito‐Cueto, Belén Atienza‐Mateo, J. Batista-Liz, María Sebastián Mora-Gil, Víctor Manuel Mora Cuesta, David Iturbe Fernandez, Sheila Izquierdo Cuervo, Carolina Aguirre Portilla, Ricardo Blanco, Raquel López‐Mejías · 2025 · Molecular Medicine
82. Long-term macrolides in diffuse interstitial lung diseases
    Paola Faverio, Francesco Bini, Adriano Vaghi, Alberto Pesci · 2017 · European Respiratory Review
83. Transcriptomic Evaluation of Pulmonary Fibrosis-Related Genes: Utilization of Transgenic Mice with Modifying p38 Signal in the Lungs
    Shuichi Matsuda, Jun‐Dal Kim, Fumihiro Sugiyama, Yuji Matsuo, Junji Ishida, Kazuya Murata, Kanako Nakamura, Kana Namiki, TATSUHIKO SUDO, Tomoyuki Kuwaki et al. · 2020 · International Journal of Molecular Sciences
84. Serum MMP-9, SP-D, and VEGF levels reflect the severity of connective tissue disease-associated interstitial lung diseases
    Chengna Lv, Qipan Zhang, Pan Tang, Lun Guo, Qunli Ding · 2022 · Revista Brasileira de Reumatologia
85. Trichostatin A attenuates ventilation-augmented epithelial-mesenchymal transition in mice with bleomycin-induced acute lung injury by suppressing the Akt pathway
    Li‐Fu Li, Chung-Shu Lee, Changwei Lin, Ning‐Hung Chen, Li‐Pang Chuang, Chen‐Yiu Hung, Yung-Yang Liu · 2017 · PLoS ONE
86. Modeling and measuring extracellular matrix alterations in fibrosis: challenges and perspectives for antifibrotic drug discovery
    Pitchumani Sivakumar, Christopher Kitson, Gábor Járai · 2018 · Connective Tissue Research
87. Kangfuxin Oral Liquid Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1/Smad Pathway
    Huan Yao, Shujun Wei, Yongjing Xiang, Ziqiang Wu, Weiwei Liu, Baojia Wang, Xueping Li, Huan Xu, Juan Zhao, Yongxiang Gao · 2019 · Evidence-based Complementary and Alternative Medicine
88. Effects of tetrandrine combined with acetylcysteine on exercise tolerance, pulmonary function and serum TNF-β1 and MMP-7 in silicosis patients
    Jing Zhang, Yingchun Wang, Shujuan Zhang, Jing Li, Hong Fang · 2020 · Experimental and Therapeutic Medicine
89. Matrix Metalloproteinases Retain Soluble FasL-mediated Resistance to Cell Death in Fibrotic-Lung Myofibroblasts
    David Nareznoi, Jenya Konikov-Rozenman, Dmytro Petukhov, Raphael Breuer, Shulamit B. Wallach‐Dayan · 2020 · Cells
90. GSK-3 Inhibition Modulates Metalloproteases in a Model of Lung Inflammation and Fibrosis
    Francesco Cinetto, Jessica Ceccato, Ilaria Caputo, Daniela Cangiano, Barbara Montini, Francesca Lunardi, Maria Piazza, Carlo Agostini, Fiorella Calabrese, Gianpietro Semenzato et al. · 2021 · Frontiers in Molecular Biosciences
91. Exposure to a Mycobacterial Antigen, ESAT-6, Exacerbates Granulomatous and Fibrotic Changes in a Multiwall Carbon Nanotube Model of Chronic Pulmonary Disease
    Anagha Malur, Barbara P. Barna · 2015 · Journal of Nanomedicine & Nanotechnology
92. HTRA1-driven detachment of type I collagen from endoplasmic reticulum contributes to myocardial fibrosis in dilated cardiomyopathy
    Hongjie Shi, Ming Yuan, Jie Cai, Lan Lan, Yumou Wang, Wei Wang, Jianliang Zhou, Bin Wang, Wenjun Yu, Zhe Dong et al. · 2024 · Journal of Translational Medicine
93. In vitro and in vivo efficacy of thiacloprid against Echinococcus multilocularis
    Chuanchuan Liu, Haining Fan, Jie Ma, Lan Ma, Ri‐Li Ge · 2021 · Parasites & Vectors
94. Reduced dynamic loads due to hip dislocation induce acetabular cartilage degeneration by IL-6 and MMP3 via the STAT3/periostin/NF-κB axis
    Yutaka Nakamura, Mitsuru Saitou, Shingo Komura, Kazu Matsumoto, Hiroyasu Ogawa, Takaki Miyagawa, Takashi Saitou, Takeshi Imamura, Yuuki Imai, Hiroshi Takayanagi et al. · 2022 · Scientific Reports
95. Breaking the Cycle: Matrix Metalloproteinase Inhibitors as an Alternative Approach in Managing Tuberculosis Pathogenesis and Progression
    Agrim Jhilta, Krishna Jadhav, Raghuraj Singh, Eupa Ray, Alok Kumar, Amit Singh, Rahul Kumar Verma · 2024 · ACS Infectious Diseases
96. Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, and Changes in Alveolar Septa in Patients with Chronic Obstructive Pulmonary Disease
    Yongxiang Zhang, Yuechuan Li, Zhen Ye, Hui Ma · 2020 · Medical Science Monitor
97. Exploration of the sputum methylome and omics deconvolution by quadratic programming in molecular profiling of asthma and COPD: the road to sputum omics 2.0
    Espen Elias Groth, Melanie Weber, Thomas Jürgen Bahmer, Frauke Pedersen, Anne‐Marie Kirsten, Daniela Börnigen, Klaus Friedrich Rabe, Henrik Watz, Ole Ammerpohl, Torsten Goldmann · 2020 · Respiratory Research
98. Pharmacological Inhibition of MMP3 as a Potential Therapeutic Option for COVID-19 Associated Acute Respiratory Distress Syndrome
    Rana Kadry, Andrea N. Sikora, Payaningal R. Somanath · 2020 · Infectious Disorders - Drug Targets
99. Targeting cIAPs attenuates CCl4-induced liver fibrosis by increasing MMP9 expression derived from neutrophils
    Yi Ming Wu, Suwen Lu, Xuan Huang, Yuanyuan Liu, Kuiyuan Huang, Ziying Liu, Weikang Xu, Wei Zhu, Jinlin Hou, Hongyan Liu et al. · 2021 · Life Sciences
100. Association of MMP‐2 and MMP‐9 expression with recurrences in primary spontaneous pneumothorax
     Ying‐Fong Huang, Wen‐Chin Chiu, Shah‐Hwa Chou, Yu‐Han Su, Yu‐Wen Chen, Chee‐Yin Chai, Chih‐Jen Huang, Ming‐Yii Huang, Shyng‐Shiou F. Yuan, Yi‐Chen Lee · 2016 · The Kaohsiung Journal of Medical Sciences